Primary Record
XMD17-109
- In stock
- 5,727 g
- Purity
- 98.3 %
- CAS
- 1435488-37-1
Compound Identifiers & Properties
- CAS
- 1435488-37-1
- PubChem CID
- 71604307
- SMILES
- CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7
- Canonical SMILES
- CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
Names & Synonyms
- XMD17-109
- ERK5-IN-1
- 1435488-37-1
- RefChem:902371
- XMD17 109
- CHEMBL2381340
- C36H46N8O3
- GTPL9406
- orb1307343
- SCHEMBL16065687
- SCHEMBL29375286
- SCHEMBL29538109
- GLXC-90052
- AOB87761
- BCP09844
- EX-A2184
- KHC48837
- XMD17109
- BDBM50434070
- compound 26 [PMID: 24239623]
- MFCD26142929
- s7334
- ZINC96270216
- AKOS025147359
- ACN-043338
- CCG-270311
- CS-1436
- SB19431
- XMD17-109?
- 11-cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one
- KS-000006B1
- compound 26 (PMID: 24239623)
- NCGC00378965-03
- AC-35970
- BC600637
- BS-15121
- HY-15665
- QC-11620
- SC-95573
- A3942
- 11-cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one
- A14090
- D71043
- W-6135
- A884918
- A920606
- BRD-K48449981-001-01-9
- BRD-K48449981-001-02-7
- 1234479-76-5
- 11-cyclopentyl-2-({2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
- 11-cyclopentyl-2-(2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)anilino)-5-methylpyrimido(4,5-b)(1,4)benzodiazepin-6-one
- 11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
- 11-cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methyl-pyrimido[4,5-b][1,4]benzodiazepin-6-one
- 110-850-5
- 2-cyclopentyl-5-({2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-9-methyl-2,4,6,9-tetraazatricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- 2-CYCLOPENTYL-5-({2-ETHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDINE-1-CARBONYL]PHENYL}AMINO)-9-METHYL-2,4,6,9-TETRAAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-10-ONE
- 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-
- 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-5,11-dimethyl-
- VYJ